Join
Live feed
·
PRReleasevia Quantisnow
Creative Medical Technology Holdings Inc. logo

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

ByQuantisnow·Wall Street's wire, on your screen.
CELZ· Creative Medical Technology Holdings Inc.
Finance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELZ (Creative Medical Technology Holdings Inc.) and more on Quantisnow.